171 related articles for article (PubMed ID: 19110624)
1. Retroviral gene transfer into primary human natural killer cells.
Alici E; Sutlu T; Sirac Dilber M
Methods Mol Biol; 2009; 506():127-37. PubMed ID: 19110624
[TBL] [Abstract][Full Text] [Related]
2. Efficient gene transfer into primary human natural killer cells by retroviral transduction.
Guven H; Konstantinidis KV; Alici E; Aints A; Abedi-Valugerdi M; Christensson B; Ljunggren HG; Dilber MS
Exp Hematol; 2005 Nov; 33(11):1320-8. PubMed ID: 16263416
[TBL] [Abstract][Full Text] [Related]
3. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector.
Becknell B; Trotta R; Yu J; Ding W; Mao HC; Hughes T; Marburger T; Caligiuri MA
J Immunol Methods; 2005 Jan; 296(1-2):115-23. PubMed ID: 15680156
[TBL] [Abstract][Full Text] [Related]
4. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.
Micucci F; Zingoni A; Piccoli M; Frati L; Santoni A; Galandrini R
Exp Hematol; 2006 Oct; 34(10):1344-52. PubMed ID: 16982327
[TBL] [Abstract][Full Text] [Related]
5. Gene Modification of Human Natural Killer Cells Using a Retroviral Vector.
Kellner JN; Cruz CR; Bollard CM; Yvon ES
Methods Mol Biol; 2016; 1441():203-13. PubMed ID: 27177668
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors.
Schroers R; Hildebrandt Y; Hasenkamp J; Glass B; Lieber A; Wulf G; Piesche M
Exp Hematol; 2004 Jun; 32(6):536-46. PubMed ID: 15183894
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements.
Ayuk F; Li Z; Kühlcke K; Lindemann C; Schade U; Eckert HG; Zander A; Fehse B
Gene Ther; 1999 Oct; 6(10):1788-92. PubMed ID: 10516731
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
Tam YK; Martinson JA; Doligosa K; Klingemann HG
Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
[TBL] [Abstract][Full Text] [Related]
9. Introduction of shRNAs into primary NK cells with lentivirus.
Kung SK
Methods Mol Biol; 2010; 612():233-47. PubMed ID: 20033645
[TBL] [Abstract][Full Text] [Related]
10. Optimization of retroviral vector generation for clinical application.
Schilz AJ; Kühlcke K; Fauser AA; Eckert HG
J Gene Med; 2001; 3(5):427-36. PubMed ID: 11601756
[TBL] [Abstract][Full Text] [Related]
11. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
[TBL] [Abstract][Full Text] [Related]
12. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
[TBL] [Abstract][Full Text] [Related]
13. Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector.
Vogt S; Ueblacker P; Geis C; Wagner B; Wexel G; Tischer T; Krüger A; Plank C; Anton M; Martinek V; Imhoff AB; Gansbacher B
Biomaterials; 2008 Mar; 29(9):1242-9. PubMed ID: 18078987
[TBL] [Abstract][Full Text] [Related]
14. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
15. Efficient retroviral gene transfer to epidermal stem cells.
Lei P; Andreadis ST
Methods Mol Biol; 2008; 433():367-79. PubMed ID: 18679635
[TBL] [Abstract][Full Text] [Related]
16. Retroviral cell targeting vectors.
Buchholz CJ; Stitz J; Cichutek K
Curr Opin Mol Ther; 1999 Oct; 1(5):613-21. PubMed ID: 11249668
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transduction of antigen-stimulated T lymphocytes with recombinant retroviruses concentrated by centrifugal filtration.
Kinyanjui MW; Ramos-Barbón D; Villeneuve A; Fixman ED
J Immunol Methods; 2006 Jul; 314(1-2):80-9. PubMed ID: 16842814
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gene transfer rate with immobilized retroviral vectors.
Peng CA
Ann N Y Acad Sci; 2009 Apr; 1161():26-33. PubMed ID: 19426303
[TBL] [Abstract][Full Text] [Related]
19. An in vitro system for efficiently evaluating gene therapy approaches to hemoglobinopathies.
Howrey RP; El-Alfondi M; Phillips KL; Wilson L; Rooney B; Lan N; Sullenger B; Smith C
Gene Ther; 2000 Feb; 7(3):215-23. PubMed ID: 10694798
[TBL] [Abstract][Full Text] [Related]
20. Purification of retrovirus particles using heparin affinity chromatography.
Segura MM; Kamen A; Garnier A
Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
